Final Agenda
Day
1- Monday, March 15th
8:30am- 9:00am Registration
9:00am- 10:30pm Session I: Welcome and MISMS overview
9:00-9:30am Mark Miller, Fogarty International Center, USA: MISMS Overview
9:30-10:00am John Mathews, University of Melbourne, Australia: The ecology of human influenza helps to explain pandemic mortality, seasonal mortality and long-term trends in mortality.
10:00-10:30am Wladimir Alonso, Fogarty International Center, Brazil: Influenza seasonality: Reconciling patterns across temperate and tropical populations.
10:30-11:00am Coffee Break
11:00am-12:40pm Session II. Disease burden and transmission dynamics of inter-pandemic influenza
11:00-11:20am Cecile Viboud, Fogarty International Center, USA: MISMS studies in tropical and temperate climates.
11:20-11:40am Chit-Ming Wong, University of Hong Kong, Hong Kong: Disease burden of influenza in three tropic and sub-tropic cities in Asia.
11:40-12:00am Vernon Lee, Ministry of Defense, Singapore: Influenza excess mortality from 1950-2000 in tropical Singapore.
12:00-12:20pm Luzhao Feng, China CDC, China: Influenza-associated deaths in Northern, Southern cities and Shanghai of China, 2003-2007
12:20-12:40pm Stephen Lambert, Queensland Paediatric Infectious Diseases Laboratory, Australia: The proportion of influenza tests that are positive: an important influenza metric unbiased by testing volume.
12:40pm-1:40pm Lunch (provided)
1:40-3:20pm. Session III. The 1918-20 influenza pandemic
1:40-2:00pm Dennis Shanks, Australian Army Malaria Institute, Australia: Highly variable mortality on isolated Pacific islands during the 1918-20 influenza pandemic.
2:00-2:20pm John Mathews, University of Melbourne, Australia: Prior immunity helps to explain wave-like behaviour of pandemic influenza in 1918-9.
2:20-2:40pm Dora Pearce, Vaccine and Immunisation Research Group (VIRGo), Australia: Understanding recurrent pandemic waves – a re-analysis of mortality rates from 333 administrative areas in England & Wales in 1918-19.
2:40-3:00pm Kirsty Joy Bolton, University of Melbourne, Australia: Alternative immune hypotheses for explaining the three mortality waves of the UK 1918-19 influenza pandemic.
3:00-3:20pm Cecile Viboud, Fogarty International Center, USA: Age mortality patterns in Europe and the Americas during the 1918 pandemic.
3:20-3:50pm Coffee break
3:50-5:30pm Session IV. Rapid reports: 2009 H1N1 pandemic in the Pacific region.
Group A: Surveillance and disease burden
3:50-4:00pm Sandra Carlson, Hunter New England Population Health, Australia: Flutracking: Measuring community influenza-like illness during a pandemic.
4:00-4:10pm David Muscatello, NSW Department of Health, Australia: All cause mortality during the first winter wave of pandemic (H1N1) 2009 virus, New South Wales, Australia.
4:10-4:20pm David Lee, National Taiwan University, Taiwan: Comparison of pandemic and inter-pandemic mortality age patterns.
4:20-4:30pm Yee Sin Leo, Tan Tock Seng Hospital, Singapore: Wide variation in H1N1-2009 seroconversion rates in Singapore: a comparative seroepidemiological study in four distinct cohorts.
4:30-4:40pm Ian Seppelt, Sydney West Area Health Service, Australia: The impact of influenza A (H1N1) 2009 on intensive care services during the Australian and New Zealand winter.
4:40-4:50pm Jen Kok, Centre for Infectious Diseases, Australia: Performance characteristics of a rapid antigen test and immunofluorescent antibody test compared with nucleic acid testing in pandemic (H1N1) 2009 influenza.
4:50-5:00pm Andrew Davies, Alfred Hospital Intensive Care Unit, Australia: Extra-corporeal Membrane Oxygenation for Novel Influenza A (H1N1) Acute Respiratory Distress Syndrome during the 2009 winter in Australia and New Zealand.
5:00-5:30pm Questions/discussion
Day
2- Tuesday, March 16th
9.00am-12.20pm Session V. Genetic and antigenic evolution of influenza viruses
9:00-9:40am Eddie Holmes, Pennsylvania State University, USA & Fogarty International Center, USA: The evolution of the influenza A virus.
9:40-10:10am Derek Smith, University of Cambridge, UK & Fogarty International Center, USA: The antigenic evolution of influenza viruses.
10:10-10:40am Andrew Rambaut, University of Edinburgh, UK & Fogarty International Center, USA: The spatial and temporal evolutionary dynamics of human influenza virus.
10:40-11:10am Coffee break
11:10-11:30am Ian Barr, WHO Collaborating Center for Reference & Research on Influenza, Melbourne, Australia: The small picture: Detection and significance of quasi species, reassortants, and antiviral resistance in human clinical samples.
11:30-11:50am Steven Barry, NCEPH, ANU, Australia: Modeling strain mutation, cross-immunity, seasonality, and global migration of influenza viruses.
11:50am-12:00pm Vuong Duc Cuong, National Influenza Centre, Vietnam: Characteristics of H5N1 viruses in Vietnam, 2003-2008.
12:00-12:20pm Martha Nelson, Fogarty International Center, USA: The early diversification of the 2009 H1N1pdm virus.
12:20-1:10pm Lunch
1:10-1:40pm Jim Bishop, Chief Medical Officer, Government Department of Health & Aging, Australia: TBA
1:40-3:00 pm Session VI. Rapid reports: 2009 H1N1 pandemic in the Pacific region
Group B. Transmission dynamics and intervention strategies
1:40-1:50pm Geoff Mercer, Australian National University, Australia: Community transmission of pandemic (H1N1) 2009 influenza was already established in Victoria, but not in Western Australia, around the time the virus was first identified in North America.
1:50-2:00pm Shui Shan Lee, The Chinese University of Hong, Hong Kong: Spatial heterogeneity in the initial spread of human swine influenza H1N1 in Hong Kong.
2:00-2:10pm Pham Quang Thai, NIHE, Vietnam: Household transmission of novel influenza H1N1, Vietnam, 2009-2010.
2:10-2:20pm Vernon Lee, Ministry of Defense, Singapore: Combination strategies are effective in mitigating pandemic influenza: Evidence from a prospective observational cohort study.
2:20-2:30pm Rob Moss, Melbourne School of Public Health, Australia: Considering the influence of health services capacity when developing antiviral deployment strategy.
2:30-3:00pm Questions/Discussion.
3:00-3:30pm Coffee break
3:40-4:50pm Session VII. Rapid reports: 2009 H1N1 pandemic in the Pacific region
Group C. Population immunity patterns
3:40-3:50pm Mark Chen, Tan Tock Seng Hospital, Singapore: Correlation between symptoms and serological infection in a sero-incidence cohort of pandemic H1N1 in Singapore – insights and implications.
3:50-4:00pm Jiehui Kevin Yin, University of Sydney, Australia: Assessing Cross Protection from 2009 Pandemic H1N1 Influenza through Absenteeism of School Teachers including Comparison with 2007 Experience.
4:00-4:10pm Jodie McVernon, Murdoch Children’s Research Institute & University of Melbourne, Australia: Immunity to influenza A H1N1 (2009) in Australian blood donors, October-December 2009.
4:10-4:20pm Heath Kelly, VIDRL, Australia: Influenza seasonal vaccine provides no protection against pandemic influenza H1N1 2009.
4:20-4:50pm Questions/discussion
4:50-5:20pm Session VIII. Options for further collaboration
4:50-5:00pm Mark Miller, Fogarty International Center, USA
5:00-5:10pm John Matthews, University of Melbourne, Australia
5:10-5:20pm Tim Nguyen, World Health Organization, Geneva, Switzerland
Day 3- Wednesday, March 17th: Workshop
9:00-10:00am Eddie Holmes, Pennsylvania State University & Fogaryt International Center, USA: Phylogenetics 101
10:00-11:00am Andrew Rambaut, University of Edinburgh, UK & FIC, USA: Practical in evolutionary analysis.
11:00-11:30am Coffee break
11:30-12:30am Andrew Rambaut, University of Edinburgh, UK & FIC, USA: Practical in evolutionary analysis. (cont.)
12:30-1:30pm Lunch
1:30-2:30pm Wladimir Alonso, FIC, USA: Practical in time-series analysis.
2:30-3:30am Derek Smith, University of Cambridge, UK & FIC, USA: Practical in evolutionary analysis: antigenic evolution.
3:30-4:00pm Coffee break
4:00-5:00am Derek Smith, University of Cambridge, UK & FIC, USA: Practical in evolutionary analysis: antigenic evolution. (cont.)
Day 4- Thursday, March 18th: Workshop
9:00-9:35am Yiming Bao, National Center for Biotechnology Information, National Library of Medicine, NIH, USA: The NCBI Influenza Virus Resource
9:35-10:30am Technical workshop
10:30-11:00am Coffee break
11:00am-12:30pm Technical workshop
12:30-1:30pm Lunch
1:30-3:00pm Technical workshop
3:00-3:30pm Coffee break
3:30-5:00pm Technical workshop
Day 5- Friday, March 19th: Workshop
Hands-on tutorial, small working groups, flexible schedule
9:00-10:30am Technical workshop
10:30-11:00am Coffee break
11:00am-12:30pm Technical workshop
12:30-1:30pm Lunch
Workshop |
Workshops
for epidemiologists and virologists led by the US National
Institutes of Health Fogarty International Center
Following
the meeting, a workshop describing the methodology to evaluate vital statistics,
virological, genomic and economic data to describe influenza disease burden and
inform policy will be held. It will consist of sessions designed for epidemiologists/virologists
and policy-makers who are interested in evaluating datasets that can be brought
to the meeting for further analysis. Workshops will concentrate on methodologies
to evaluate time-series data for regional or national analysis of influenza disease
burden, assessments of control, and evolution of influenza viruses. Participants
will have the opportunity to learn and apply tools to analyze national datasets
and formulate further collaborations on bi-national and multinational studies.
Please note that participation in the Thursday and Friday workshop sessions will
be limited. Participation will be based on submitted abstracts, which should include
a description of available datasets that participants may want to further analyze.
It
is highly recommended, but not required, that participants in the workshop bring:
- a laptop with some type of statistical software (SAS recommended)
- an influenza
dataset (vital statistics data, influenza isolate data, and vaccine coverage)
Individuals
who attend the workshop will have the opportunity to learn about:
- time series
analysis
- spatial / temporal relationships
- influenza genomics tools
- data management issues
- SAS / Stata code - go home with your own programs
- strategies for evaluating vaccine benefits in a country using mortality data
- and more!
|
|
